Ara
Toplam kayıt 19, listelenen: 1-10
Status of the epicardial coronary arteries in non-ST elevation acute coronary syndrome in patients with mechanical prosthetic heart valves (from the TROIA-ACS Trial)
(Elsevier Inc., 2018)
Coronary thromboembolism (CE) is a rare cause of prosthetic valve derived complications. This study investigates the diagnosis and treatment strategies for non-ST elevation acute coronary syndrome (NSTEACS) in patients ...
Complementary role of cardiac computed tomography to transesophageal echocardiography in the evaluation of prosthetic valve dysfunction
(Elsevier Ireland Ltd, 2017)
Dear Editor,
We have read with great interest the article by Suh et al. describingtheadded value of cardiaccomputed tomography(CT) in theevaluationof pannus overgrowth on mechanical prosthetic valves[1]. Cardiac CThas a ...
The relationship between heparanase levels, thrombus burden and thromboembolism in patients receiving unfractionated heparin treatment for prosthetic valve thrombosis
(Elsevier Ltd, 2018)
Introduction: Procoagulant activity of heparanase has been recently described in several arterial and venous thrombotic disorders. In this study, we aimed to investigate the role of heparanase with regard to thrombus burden, ...
The role of protein Z and protein Z-dependent protease ınhibitor polymorphisms in the development of prosthetic heart valve thrombosis
(2017)
BACKGROUND AND AIM OF THE STUDY: Protein Z (PZ) is a vitamin K-dependent factor that is synthesized mainly by the liver. It acts as an activator of serpin, the protein Z-dependent inhibitor (ZPI), which inhibits factor Xa. ...
How to perform and manage low-dose and slow/ultra-slow tissue type plasminogen activator infusion regimens in patients with prosthetic valve thrombosis
(Springer New York LLC, 2018)
Over the last two decades, thrombolytic therapy (TT) has become an alternative to surgery as a first-line therapy in patients with thrombosed mechanical valves [1, 2, 3]. In TROIA Trial, low dose (25 mg)—slow infusion (6 ...
What is the importance of real-time three dimensional transesophageal echocardiography and time in therapeutic range in patients with prosthetic valve thrombosis?
(Springer New York LLC, 2018)
We have recently read with great interest the article reported by Cınar et al. which was published in the last issue of the Journal of Thrombosis and Thrombolysis [1]. We appreciate the authors for their report describing ...
Evaluation of the potential predictors of embolism in patients with left atrial myxoma
(Blackwell Publishing Inc., 2019)
Introduction: Cardiac myxomas are the most common primary intracardiac tumors. Although myxomas are histologically benign, they are potentially dangerous due to potential risk of systemic and cerebral embolism. In this ...
Comparison of different anticoagulation regimens in pregnant patients with mechanical prosthetic heart valves
(Oxford Univ Press, 2017)
[Abstract Not Available]
Noninvasive diagnostic tools available for discrimination pannus from thrombus in patients with prosthetic valve dysfunction
(Blackwell Publishing Inc., 2019)
We have recently read with great interest the article by Barroso Freitas‐Ferraz et al1 entitled “Prosthetic aortic valve thrombosis: To fibrinolyse or not to fibrinolyse? That is the question!”. The authors reported a case ...
Management of antithrombotic therapy after prosthetic valve implantation
(John Wiley and Sons Inc, 2021)
To the Editor,
We have recently read with great interest the article by Wei et al. entitled “Recurrent prosthetic valve dysfunction in a patient with idiopathic hypereosinophilic syndrome: A case report and literature ...